- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 11/00 - Depsipeptides ayant jusqu'à 20 amino-acides dans une séquence entièrement déterminéeLeurs dérivés
Détention brevets de la classe C07K 11/00
Brevets de cette classe: 123
Historique des publications depuis 10 ans
|
6
|
7
|
10
|
11
|
10
|
6
|
3
|
10
|
5
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Onkure, Inc. | 31 |
5 |
| Massachusetts Institute of Technology | 10259 |
4 |
| Sanofi | 4316 |
4 |
| Novartis AG | 10224 |
3 |
| The Regents of the University of California | 20790 |
3 |
| President and Fellows of Harvard College | 6096 |
3 |
| Bayer Cropscience LP | 270 |
2 |
| Board of Regents, The University of Texas System | 6127 |
2 |
| Agency for Science, Technology and Research | 3744 |
2 |
| University of Florida Research Foundation, Inc. | 4183 |
2 |
| The Broad Institute, Inc. | 1979 |
2 |
| Chugai Seiyaku Kabushiki Kaisha | 1421 |
2 |
| Karus Therapeutics Limited | 27 |
2 |
| Nanyang Technological University | 2212 |
2 |
| Osaka Prefecture University Public Corporation | 230 |
2 |
| The Regents of the University of Colorado, a body corporate | 2812 |
2 |
| Shenzhen Institutes of Advanced Technology | 1528 |
2 |
| Stella Pharma Corporation | 40 |
2 |
| University of Vermont and State Agricultural College | 400 |
2 |
| The USA, as represented by the Secretary, Dept. of Health and Human Services | 87 |
2 |
| Autres propriétaires | 73 |